1% polidocanol endovenous microfoam (Varithena(TM)) for the treatment of chronic venous disease: A position statement from the American vein and lymphatic society.
- DOI
- 10.1177/02683555251353150
- Published
- 2026 Mar
- Container
- Phlebology
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1177/02683555251353150,
title = {1\% polidocanol endovenous microfoam (Varithena(TM)) for the treatment of chronic venous disease: A position statement from the American vein and lymphatic society.},
author = {Meissner MH and Di Iorio M and Davies A},
year = {2026},
journal = {Phlebology},
doi = {10.1177/02683555251353150},
url = {https://doi.org/10.1177/02683555251353150}
}RIS
TY - JOUR TI - 1% polidocanol endovenous microfoam (Varithena(TM)) for the treatment of chronic venous disease: A position statement from the American vein and lymphatic society. AU - Meissner MH AU - Di Iorio M AU - Davies A PY - 2026 JO - Phlebology DO - 10.1177/02683555251353150 UR - https://doi.org/10.1177/02683555251353150 ER -
APA
MH, M., M, D. I., & A, D. (2026). 1% polidocanol endovenous microfoam (Varithena(TM)) for the treatment of chronic venous disease: A position statement from the American vein and lymphatic society.. Phlebology. https://doi.org/10.1177/02683555251353150
Source records
- pubmed · retrieved 2026-09-27T10:14:31.504Z